Summary

  • Beximco Pharmaceuticals Ltd. (DSE:BEXIMCO, CSE:BEXIMCO) was founded in 1976 and started its operations in 1980.
  • The company launched its formulation brand in 1983.
  • With an 8.39% market share (based on profit), the company is now holding the third position in the pharmaceuticals industry in Bangladesh.
  • Approximately 4,700 people work at Beximco Pharma and the company has a presence in more than 80 countries. The export earnings of Beximco Pharmaceuticals Ltd. amounted to 32.46 million dollars in the 2018-19 fiscal year.
  • Beximco pharma is the first-ever pharmaceutical company from Bangladesh to explore the US market in 2016.
  • The company has made its share market debut in 1985 by getting listed in Dhaka Stock Exchange (DSE).
  • The company acquired an 85.22 percent stake of Nuvista Pharma in 2018 and a 54.6 percent stake of Sanofi Bangladesh in 2021.
  • Beximco Pharma has reported BDT 370.60 crore profit in the first nine months of FY21
  • The company has achieved the Global Generics and Biosimilars Awards 2021 in the category of Company of the Year, Asia Pacific.

Company Overview

Beximco Pharmaceuticals Ltd. is one of the leading drug manufacturers and exporters in Bangladesh. Based in Dhaka, the company is a part of Beximco Group and playing an active role in the pharmaceuticals industry of the country. The company was founded in 1976 and started its operation in 1980.1 The company started mbeximco logoanufacturing its own products under proper licensing in 1980 and prior to that it used to import products from Germany and USA. In 1983 the company launched its own formulation brands and put a step ahead in the journey.

Currently, the company is holding the third position in the pharmaceuticals industry of Bangladesh with an 8.39% market share (based on profit).2 Its major competitors are Square Pharmaceuticals (16% market share), Incepta (10.21% market share), and Opsonin (5.54% market share). Right now, Beximco Pharma employs more than 4,700 people. The company is currently producing 300+ generic medicines. The company’s portfolio includes antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, dermatology, gastrointestinal, and more.

Beximco Pharmaceuticals Ltd. has a presence in more than 80 countries and it has expanded its global consumer base through exporting in some highly regulated markets in the last decade. In 2018-19 fiscal year, the export earnings of Beximco Pharmaceuticals Ltd. amounted to 32.46 million USD - the highest among other companies in the country that year. Moreover, Beximco pharma is the first-ever pharmaceutical company in Bangladesh that has explored the US market in 2016. The company has also introduced the world's first generic remdesivir for Covid-19 treatment in 2020.

Beximco Pharma has made its share market debut in 1985 by getting listed in Dhaka Stock Exchange (DSE). Currently, the company is also listed on Chittagong Stock Exchange (CSE) – second of the two stock exchanges of the country, and Alternative Investment Market (AIM) at London Stock Exchange.

The company has a mission to enhance human health and well-being through providing contemporary and affordable medicines while maintaining global quality standards. Moreover, the company has a vision of becoming the most trusted, admired, and successful pharmaceutical company in the region. Beximco is determined to attain this standard through strengthening research and development capabilities and building a strong presence in the global market.

Beximco has achieved several national and international awards for its outstanding contribution to the pharmaceutical industry of Bangladesh. It is the only Company in the region that won the highly prestigious SCRIP Award as the “Best Pharma Company in an Emerging Market”3 and also the Global Generics and Biosimilars Awards 2021 in the category of Company of the Year, Asia Pacific.4

History of Beximco

The Acquisitions of Beximco Pharma

Beximco Pharma had acquired an 85.22 percent stake in Nuvista Pharma in 2018. 5 Nuvista Pharma is a leading manufacturer of hormonal drugs and steroids in Bangladesh. Nuvista Pharma was a subsidiary of Netherlands-based Organon Holding BV. in 1973 the company was incorporated as Organon (Bangladesh) Limited. Later on, Organon Holding BV divested its shares in Organon (Bangladesh) Limited to the local management, and accordingly, the name of the company was changed to Nuvista Pharma Ltd. The company manufactures different pharmaceutical products such as oral contraceptives, hormones, antihistamines, steroids, and so on. Nuvista generated 171 crore BDT in revenue, 11.8 crore BDT in profit before tax, and 54.8 crore BDT worth net assets in FY 2016-17. The 12.92 percent stake of Nuvista is owned by the Govt. of Bangladesh.

The two companies (Beximco Pharma and Nuvista Pharma)  signed a non-binding Memorandum Of Understanding (MOU) on October 5, 2017 to work through the acquisition process, which had been finalised on January 18, 2018. This is the first-ever acquisition in the history of the pharmaceuticals industry of Bangladesh.sanofi bangladesh ownership structure

Again in 2021, Beximco pharma acquired the majority stake (54.6 percent) of Sanofi Bangladesh – a multinational pharmaceutical company. In Bangladesh, Sanofi started its operation in 1958 as “May and Baker” which was renamed “Sanofi Bangladesh Ltd.” in 2013. The company had generated 388 crore BDT in revenue, 49.79 crore BDT in profit before tax, and 609 crore BDT worth of gross assets as of 2019.

The acquisition has cost Beximco Pharma up to  400 crore BDT which is the biggest takeover in the Pharma Industry of the country so far. Regarding the acquisition, Nazmul Hassan MP, managing director of Beximco Pharma, expressed that Beximco Pharma has a proper strategy to continue its diversification and expansion while establishing the company as a leading pharma company in the region. He also added that the acquisition is a part of their growth strategy. 6

Industry overview

The pharmaceuticals industry in Bangladesh was once dependent heavily on imports and multinational companies. But now the industry is growing very fast to meet 98% of the domestic demand. The remaining 2% are specialized imports like vaccines, hormone drugs, anti-cancer products and so on. The industry is also exporting to different parts of the world and posting a growth rate of 27% per year in export earnings. In 2018, the industry stood at BDT 205 billion in terms of market size with a compound annual growth rate of 15.6% for the last five years. The industry is expected to grow at a rate of 15% per year to reach $5.11 billion by 2023.

industry overview

The industry in Bangladesh has found its strengths in the 80s. Over the past 4 decades, the industry has grown to a billion-dollar industry by developing thousands generic drugs and producing other thousands patented drugs. The drugs produced in the country are divided into two parts – 80% are generic, 20% are patented drugs. Different lines of drugs are being produced in the country including Allopathic, Homeopathic, Unani, Ayurvedic, and Herbal.

types of medicines being produced in Bangladesh

Key growth drivers of the industry

Bangladesh has posted stellar economic growths in the past years until the covid-19 pandemic has come and caused a slip in the GDP growth rate. The country has achieved a growth rate of 7.28% in FY17 and 7.86%, 8.15%, 3.51% in the following financial years. According to Bangladesh Bureau of Statistics (BBS), provisional estimate of GDP for the country in FY21 is 5.47%. The country is experiencing a population growth rate of 1% every year. Per capita income of the country stands at $2,227 in FY21, an increase of $203 from previous fiscal year. Consumption expenditure of the country in FY21 is 75.83% of GDP. Domestic savings increased in FY21 to 24.17% of GDP from 23.77% of GDP a year earlier. Public and private investment together combines to 7.95% of GDP.7 Higher economic growth, increase in disposable income, population growth rate, and changes in pattern of disease are the key drivers for pharmaceuticals industry in Bangladesh. People are also becoming more aware about the facilities they can receive through the pharmaceuticals industry in the country. Apart from that changed life style, improved life expectancy, health awareness, and modern healthcare facilities cause drive in the pharmaceuticals industry.

key growth drivers of pharma industry

Porter’s five forces analysis

Porter’s five forces is a model developed by Michael E. Porter of Harvard University in 1979. The model assesses the competitiveness of an industry and the profitability of the companies given the competition.

Threat of new entrant in this industry is lower because a new aspirant in the industry will need huge capital investment and many regulatory permissions in order to start producing drugs. The brand loyalty of the customers is another factor contributing to the barrier of entry.

Threat of substitute products at industry level is low because the companies produce all types of drugs such as allopathic, homeopathic, unani, ayurvedic, and harbal. So, to cure a disease when prescribed a medicine, the consumers will have to come to the industry. But at a company-level, the threat of substitute products is high.

Bargaining power of the buyers is very low in the industry. The patients need to depend on the prescribed products by the doctors and they cannot but buy the drugs at a price setup by the pharmaceutical companies. However, the government has regulations regarding prices of different lifesaving drugs. But those are often not up to the mark for compliance.

Bargaining power of the suppliers is very high. Bangladesh imports over 90% raw materials for pharmaceutical industry worth Tk 47 billion. This makes the bargaining power of the suppliers high and the companies also remain vulnerable to external shocks. Oftentimes, the price of the drugs in the industry fluctuates due to high import costs. However, Bangladesh has laid the foundation to manufacture at least half the raw materials inside the country. Active Pharmaceutical Ingredients (API) Industrial Park is being constructed in Gazaria, Munshiganj.

Rivalry among the top players in the industry is very high. About 68% of the market is controlled by top 10 companies. For a generic medicine class all the companies have a brand which competes against each other in the market.

Financial performance

Beximco Pharmaceuticals Ltd. has made BDT 370.60 crore profit in the first nine months of the 2020profit performance of Beximco-2021 financial year which is a 41.28% increase from the same period of the last year (BDT 262.31 crore).8 The company’s Earnings Per Share (EPS) for the 2020-2021 financial year was BDT 8.23, while it was 5. 84 in the last year. The net profit of the company in the last quarter of 2020-2021 financial year was BDT 147 crore while it was BDT 90.92 crore for the same period last year. Beximco Pharma’s net asset value (NAV) was BDT 82.28 for the year ended on June 30, 2021, while it was BDT 79.78 last year.9 The company has provided BDT 12.50 dividend in 2018, BDT 15.00 in 2019, and BDT 15.00 along with a 10% stock dividend in 2020. The company’s dividend yield was 1.80 percent in 2019 and 2.17 percent in 2020. Moreover, its payout ratio was 20.05% and 17.30% in 2019 and 2020, respectively.

The Covid-19 pandemic has evidently brought fortune for Beximco Pharma. The company has generated BDT 1,440 crore total sales in the first half of the 2020-2021 financial year which shows a 15.2% increase in sales from the previous year. And this year the sales have increased more. In the first quarter of the 2021-2022 financial year, the company has reported BDT 847 crore sales as against BDT 693 crore in the same quarter last year.

Share market activities

In 1985, Beximco Pharma started its share market journey by getting listed on Dhaka Stock Exchange (DSE). In 1995, the company got listed on Chittagong Stock Exchange (CSE) – the second stock exchange in the country. It is the only company in Bangladesh that was able to raise funds from an overseas stock market. In 2005, as the first-ever company from the country, Beximco Pharma got listed at Alternative Investment Market (AIM) of London Stock Exchange. The company sells GDRs (global depositary receipt) only in the Alternative Investment Market (AIM) of London Stock Exchange. The company’s paid-up share capital consists of 446.11 million ordinary shares of BDT 10 each which includes Shares listed with local Stock Exchanges of Bangladesh (346.07 million, 77.58%) and underlying shares against the GDRs (one share against each GDRs) listed on AIM(100.04 million, 22.42%). The company’s last trading price was BDT 206.10 on 09 December, 2021. Beximco Pharma has declared a 35 percent cash dividend to its shareholders for the financial year 2020-2021, while its major competitor Square Pharmaceuticals Ltd. has declared a 60 percent cash dividend for the same period.10

Recent events

Beximco Pharma is the first-ever company in Bangladesh that got permission to hit the American market, the largest and one of the most lucrative pharmaceuticals markets in the world. The company got permission to export products from the US Food and Drug Administration (FDA) in November, 2016. The company has been awarded as one of the top taxpayer companies from the Large Taxpayer Unit of NBR (National Board of Revenue) for the financial year 2020-2021. In July, 2021, the company has received FDA (US Food and Drug Administration) approval for a muscle relaxant medicine, Baclofen. And with this approval, the company will be exporting its ninth product fully developed in-house and successfully approved for the US market.11 Amid the Coronavirus pandemic, Beximco Pharma’s investment has grown exponentially. The company has invested BDT 1,000 crore in establishing  ‘Unit III’ solids, semi-solids, and liquids facilities in Tongi as of September, 2021. The project is expected to end by this year and the company expects that the project will be proved profitable for Beximco Pharma in the upcoming days. 

  1. ^ https://www.beximcopharma.com/about-us
  2. ^ https://businessinspection.com.bd/pharmaceutical-industry-of-bangladesh/
  3. ^ https://m.theindependentbd.com/post/126524
  4. ^ https://www.daily-sun.com/magazine//details/587994/Beximco-Pharma-wins-Global-Generics--Biosimilars-Awards
  5. ^ https://www.thedailystar.net/business/beximco-acquires-85pc-nuvista-1557673
  6. ^ https://www.dhakatribune.com/business/2021/10/02/beximco-pharma-completes-acquisition-of-a-majority-stake-in-sanofi-bangladesh-limited
  7. ^ https://mof.portal.gov.bd/sites/default/files/files/mof.portal.gov.bd/page/f2d8fabb_29c1_423a_9d37_cdb500260002/10.%20Chapter-01%20Eng%20Eng-21.pdf
  8. ^ https://www.dhakatribune.com/business/stock/2021/04/29/beximco-pharma-reports-41-profit-in-march-for-fy21
  9. ^ https://thefinancialexpress.com.bd/stock/beximco-pharma-posts-47pc-growth-square-14pc-in-net-profit-1635046169
  10. ^ https://www.tbsnews.net/economy/stocks/8-companies-declare-dividends-2021-319171
  11. ^ https://www.beximcopharma.com/newsroom/news-Details/beximco-pharma-receives-us-fda-approval-for-muscle-relaxant-drug-baclofen
Created by MD. TOUHIDUL ISLAM on 2021/12/06 03:22
     

Become a Contributor

If you follow a company closely and would like to share your knowledge, we would love your contributions. Register Now and start editing!

Tag Cloud

  1. AU:DTL
  2. AU:PNC
  3. AU:SSR
  4. Bangladesh
  5. BD:ACI
  6. BD:AMCL(PRAN)
  7. BD:BATBC
  8. BD:BERGERPBL
  9. BD:BEXIMCO
  10. BD:BSRMLTD
  11. BD:GP
  12. BD:KOHINOOR
  13. BD:LANKABAFIN
  14. BD:MARICO
  15. BD:PREMIERCEM
  16. BD:RBBL
  17. BD:RENATA
  18. BD:ROBI
  19. BD:SINGERBD
  20. BD:SQURPHARMA
  21. BD:WALTONHIL
  22. CA:ABX
  23. CA:AC
  24. CA:AEM
  25. CA:AFI
  26. CA:AGI
  27. CA:BAM.A
  28. CA:BCE
  29. CA:BLDP
  30. CA:BMO
  31. CA:BNS
  32. CA:BTO
  33. CA:CCO
  34. CA:CM
  35. CA:CNQ
  36. CA:CNR.TO
  37. CA:CP
  38. CA:CSU
  39. CA:CU
  40. CA:CVE
  41. CA:EMA
  42. CA:ENB
  43. CA:FFH
  44. CA:FM
  45. CA:FSV
  46. CA:FTS
  47. CA:GFL
  48. CA:GIB
  49. CA:GWO
  50. CA:IFC
  51. CA:IMO
  52. CA:K
  53. CA:LULU
  54. CA:MFC
  55. CA:MG
  56. CA:MRU
  57. CA:MX
  58. CA:NA
  59. CA:NG
  60. CA:NTR
  61. CA:OTEX
  62. CA:POW
  63. CA:PVG
  64. CA:QSR
  65. CA:RBA
  66. CA:RCI.A
  67. CA:RY
  68. CA:SHOP
  69. CA:SJR.B
  70. CA:SLF
  71. CA:SSRM
  72. CA:SU
  73. CA:T
  74. CA:TA
  75. CA:TARD
  76. CA:TD
  77. CA:TECK
  78. CA:TFII
  79. CA:TRI
  80. CA:TRP
  81. CA:WEED
  82. CA:X
  83. CA:YRI
  84. Canada
  85. CH:ALSN
  86. CH:NESN
  87. CIPLA
  88. DE:TIMA
  89. EU:CCAP
  90. EU:HHFA
  91. FR:CEN
  92. FR:HCO
  93. GB:AAL
  94. GB:ABDN
  95. GB:ABF
  96. GB:ADM
  97. GB:AHT
  98. GB:ANTO
  99. GB:AUTO
  100. GB:AUY
  101. GB:AV
  102. GB:AVST
  103. GB:AVV
  104. GB:AZN
  105. GB:BA
  106. GB:BARC
  107. GB:BATS
  108. GB:BDEV
  109. GB:BHP
  110. GB:BME
  111. GB:BP
  112. GB:CCH
  113. GB:CPG
  114. GB:CTO
  115. GB:DARK
  116. GB:DGE
  117. GB:FERG
  118. GB:GLEN
  119. GB:HL
  120. GB:HSBA
  121. GB:IHG
  122. GB:III
  123. GB:IMB
  124. GB:INCH
  125. GB:NWG
  126. GB:NXR
  127. GB:OCDO
  128. GB:REL
  129. GB:RKT
  130. GB:SGE
  131. GB:SGRO
  132. GB:SKG
  133. GB:SMIN
  134. GB:SN
  135. GB:STAN
  136. GB:STJ
  137. GB:ULVR
  138. Great Britain
  139. HK:0995
  140. HK:1052
  141. HK:107
  142. HK:189
  143. HK:548
  144. HK:819
  145. HK:995
  146. IN:3MINDIA
  147. IN:ADANITRANS
  148. IN:BHARATFORG
  149. IN:CIPLA
  150. IN:CROMPTON
  151. IN:GODREJIND
  152. IN:HDFCAMC
  153. IN:IDEA
  154. IN:INDUSTOWER
  155. IN:LICI
  156. IN:LUPIN
  157. IN:LUPINE
  158. IN:MFSL
  159. IN:MOFSL
  160. IN:MOTHERSUMI
  161. IN:MUTHOOTFIN
  162. IN:NATCOPHARM
  163. IN:NATIONALUM
  164. IN:NBCC
  165. IN:NESTLEIND
  166. IN:NIACL
  167. IN:NMDC
  168. IN:OBEROIRLTY
  169. IN:OFSS
  170. IN:PAGEIND
  171. IN:PAYTM
  172. IN:PEL
  173. IN:PETRONET
  174. IN:PFIZER
  175. IN:PGHH
  176. IN:PIDILITIND
  177. IN:PIIND
  178. IN:PNB
  179. IN:PNBHOUSING
  180. IN:POWERGRID
  181. IN:QUESS
  182. IN:RAMCOCEM
  183. IN:RELAXO
  184. IN:SAIL
  185. IN:SANOFI
  186. IN:SBILIFE
  187. IN:SIEMENS
  188. IN:SRF
  189. IN:SUPREMEIND
  190. IN:TATAPOWER
  191. IN:TECHM
  192. IN:TITAN
  193. IN:TORNTPHARM
  194. IN:TORNTPOWER
  195. IN:TRENT
  196. IN:TVSMOTOR
  197. IN:UBL
  198. IN:ULTRACEMCO
  199. IN:UNIONBANK
  200. IN:UPL
  201. IN:VBL
  202. IN:WHIRLPOOL
  203. IN:ZEEL
  204. India
  205. Ireland
  206. JP:1070
  207. JP:2654
  208. JP:4220
  209. JP:4734
  210. JP:6916
  211. SG:BCY
  212. SG:F13
  213. UK:IHG
  214. US:AABA
  215. US:AAOI
  216. US:AAPL
  217. US:AAUKF
  218. US:ABEO
  219. US:ABUS
  220. US:ACAD
  221. US:ACAN
  222. US:ACBFF
  223. US:ACDVF
  224. US:ACHN
  225. US:ACIA
  226. US:ACRX
  227. US:ADAP
  228. US:ADMP
  229. US:ADMS
  230. US:ADXS
  231. US:AEM
  232. US:AEZS
  233. US:AFMD
  234. US:AGEN
  235. US:AGI
  236. US:AGRX
  237. US:AGTK
  238. US:AKAO
  239. US:ALDR
  240. US:ALIM
  241. US:ALQA
  242. US:AMC
  243. US:AMD
  244. US:AMDA
  245. US:AMIGF
  246. US:AMMJ
  247. US:AMN
  248. US:AMPE
  249. US:AMRN
  250. US:AMRS
  251. US:AMZN
  252. US:ANCUF
  253. US:ANFGF
  254. US:ANLDF
  255. US:ANTH
  256. US:ANY
  257. US:APHQF
  258. US:AQMS
  259. US:AQSZF
  260. US:ARDX
  261. US:ARGS
  262. US:ARLZ
  263. US:ARNA
  264. US:ARRY
  265. US:ARWR
  266. US:ASBFF
  267. US:ASHTF
  268. US:ATDRY
  269. US:ATHX
  270. US:ATNM
  271. US:ATOS
  272. US:ATRS
  273. US:AUPH
  274. US:AUY
  275. US:AVASF
  276. US:AVEO
  277. US:AVEVF
  278. US:AVGR
  279. US:AVIR
  280. US:AVP
  281. US:AVVIY
  282. US:AVXL
  283. US:AXON
  284. US:AXSM
  285. US:AZN
  286. US:BABA
  287. US:BAC
  288. US:BAESF
  289. US:BAM
  290. US:BBRY
  291. US:BCE
  292. US:BCOR
  293. US:BCS
  294. US:BHC
  295. US:BHP
  296. US:BIOA
  297. US:BIOC
  298. US:BLCM
  299. US:BLDP
  300. US:BLEVF
  301. US:BLOZF
  302. US:BLPH
  303. US:BLRX
  304. US:BMO
  305. US:BMRPF
  306. US:BNS
  307. US:BP
  308. US:BPMX
  309. US:BSTG
  310. US:BTDPF
  311. US:BTE
  312. US:BTG
  313. US:BTI
  314. US:BW
  315. US:BZUN
  316. US:CALA
  317. US:CANN
  318. US:CAPR
  319. US:CARA
  320. US:CASC
  321. US:CATB
  322. US:CBDS
  323. US:CCJ
  324. US:CEI
  325. US:CERC
  326. US:CERU
  327. US:CHK
  328. US:CIE
  329. US:CLDX
  330. US:CLF
  331. US:CLOV
  332. US:CLSN
  333. US:CLVS
  334. US:CM
  335. US:CMPGF
  336. US:CNAB
  337. US:CNAT
  338. US:CNBX
  339. US:CNI
  340. US:CNQ
  341. US:CNSWF
  342. US:CORT
  343. US:CP
  344. US:CPRX
  345. US:CRBP
  346. US:CRIS
  347. US:CRMD
  348. US:CTRV
  349. US:CU
  350. US:CUR
  351. US:CVE
  352. US:CVSI
  353. US:CYCC
  354. US:CYTR
  355. US:CYTX
  356. US:DCTH
  357. US:DEPO
  358. US:DGEAF
  359. US:DMPI
  360. US:DRKTF
  361. US:DRYS
  362. US:DVAX
  363. US:DXTR
  364. US:DYLLF
  365. US:EARS
  366. US:ECYT
  367. US:EDIT
  368. US:EGLT
  369. US:EKSO
  370. US:ELVT
  371. US:ENB
  372. US:ENDP
  373. US:ENRT
  374. US:ETRM
  375. US:EVC
  376. US:EXEL
  377. US:FATE
  378. US:FB
  379. US:FERG
  380. US:FINL
  381. US:FIT
  382. US:FLXN
  383. US:FOLD
  384. US:FQVLF
  385. US:FRFHF
  386. US:FSV
  387. US:FTR
  388. US:FTS
  389. US:FVE
  390. US:FWDG
  391. US:GALE
  392. US:GALT
  393. US:GBHPF
  394. US:GBT
  395. US:GERN
  396. US:GFL
  397. US:GIB
  398. US:GILD
  399. US:GLDFF
  400. US:GLEN
  401. US:GLYC
  402. US:GME
  403. US:GNCA
  404. US:GNMX
  405. US:GOLD
  406. US:GPRO
  407. US:GSAT
  408. US:GVXXF
  409. US:GWLIFU
  410. US:HLTH
  411. US:HMNY
  412. US:HRGLF
  413. US:HRTX
  414. US:HSBA
  415. US:HTGM
  416. US:HTZ
  417. US:HUSA
  418. US:ICPT
  419. US:IDRA
  420. US:IDXG
  421. US:IFCZF
  422. US:IHG
  423. US:IMBBF
  424. US:IMGN
  425. US:IMMU
  426. US:IMNP
  427. US:IMO
  428. US:IMUC
  429. US:INFI
  430. US:INPX
  431. US:INSM
  432. US:INVA
  433. US:ITEK
  434. US:IVITF
  435. US:JD
  436. US:JOBS
  437. US:JVA
  438. US:KAYS
  439. US:KEM
  440. US:KERX
  441. US:KGC
  442. US:KTOS
  443. US:KTOV
  444. US:LKM
  445. US:LODE
  446. US:LPCN
  447. US:LULU
  448. US:LXRP
  449. US:MACK
  450. US:MARA
  451. US:MBOT
  452. US:MBRX
  453. US:MDCL
  454. US:MDCO
  455. US:MEET
  456. US:MEIP
  457. US:MEOH
  458. US:MFC
  459. US:MGA
  460. US:MGWFF
  461. US:MNKD
  462. US:MOMO
  463. US:MQPXF
  464. US:MRNS
  465. US:MRTX
  466. US:MSFT
  467. US:MTRAFU
  468. US:MU
  469. US:MVIS
  470. US:MZOR
  471. US:NAK
  472. US:NBEV
  473. US:NBRV
  474. US:NEOS
  475. US:NG
  476. US:NH
  477. US:NLNK
  478. US:NMUS
  479. US:NTIOF
  480. US:NTNX
  481. US:NTR
  482. US:NVAX
  483. US:NVCN
  484. US:NVDA
  485. US:NVRO
  486. US:NWBO
  487. US:NWG
  488. US:NXTTF
  489. US:NYMX
  490. US:OCDGF
  491. US:OCLR
  492. US:OCUL
  493. US:OGRMF
  494. US:OMER
  495. US:ONCS
  496. US:ONTX
  497. US:ONVO
  498. US:OPGN
  499. US:OPHT
  500. US:OPK
  501. US:OPTT
  502. US:OTEX
  503. US:OTIC
  504. US:P
  505. US:PANXF
  506. US:PBYI
  507. US:PETS
  508. US:PETX
  509. US:PGNX
  510. US:PHOT
  511. US:PIRS
  512. US:PLSE
  513. US:PLUG
  514. US:PLX
  515. US:PRTO
  516. US:PSDV
  517. US:PTI
  518. US:PTN
  519. US:PTX
  520. US:PUFXF
  521. US:PULM
  522. US:PVG
  523. US:QRSRF
  524. US:QSR
  525. US:RAD
  526. US:RBA
  527. US:RBGPF
  528. US:RCI
  529. US:RCKT
  530. US:RDHL
  531. US:RDUS
  532. US:RELX
  533. US:REPH
  534. US:RGLS
  535. US:RIGL
  536. US:RNN
  537. US:RNVA
  538. US:ROX
  539. US:RSSFF
  540. US:RTTR
  541. US:RY
  542. US:SCYX
  543. US:SDRL
  544. US:SEGXF
  545. US:SENS
  546. US:SESN
  547. US:SGBY
  548. US:SGGEF
  549. US:SGMO
  550. US:SGYP
  551. US:SHOP
  552. US:SJR
  553. US:SKLN
  554. US:SLF
  555. US:SLFPF
  556. US:SMFTF
  557. US:SMGKF
  558. US:SNAP
  559. US:SNN
  560. US:SPHS
  561. US:SPLIF
  562. US:SPRWF
  563. US:SQ
  564. US:SRNA
  565. US:SRNE
  566. US:SRRA
  567. US:SSRM
  568. US:STJPF
  569. US:STLY
  570. US:STML
  571. US:STMP
  572. US:STRRF
  573. US:SU
  574. US:SWN
  575. US:SYN
  576. US:TAC
  577. US:TBQBF
  578. US:TD
  579. US:TECK
  580. US:TENX
  581. US:TEVA
  582. US:TFII
  583. US:TGOPF
  584. US:TGTX
  585. US:THCBF
  586. US:TK
  587. US:TMXXF
  588. US:TNDM
  589. US:TOP
  590. US:TRI
  591. US:TROV
  592. US:TRP
  593. US:TRTC
  594. US:TRVN
  595. US:TRXC
  596. US:TSG
  597. US:TSLA
  598. US:TTM
  599. US:TTNP
  600. US:TTNQY
  601. US:TU
  602. US:TVTY
  603. US:TWTR
  604. US:TXMD
  605. US:UBQU
  606. US:UNXL
  607. US:VAPE
  608. US:VBLT
  609. US:VCEL
  610. US:VDQSF
  611. US:VPCO
  612. US:VSTM
  613. US:WIT
  614. US:WLDFF
  615. US:WLL
  616. US:WMIH
  617. US:WMT
  618. US:XGTI
  619. US:XON
  620. US:XTNT
  621. US:XXII
  622. US:ZGNX
  623. US:ZSAN
  624. US:ZYNE
This site is funded and maintained by Fintel.io